PATENT CLAIM ANALYSIS

Application Number: 16048665
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2018-11
Patent Classification: ["514", "211150"]

Abstract:
The invention relates to morpholine and 1,4-oxazepane amide derivatives of general formula (I), which are agonists of somatostatin receptor subtype 4 (SSTR4), useful for preventing or treating medical disorders related to SSTR4. In addition, the invention relates to processes for preparing pharmaceutical compositions as well as processes for manufacture of the compounds according to the invention.

Claim (Index 17):
The compound according to  claim 16 , or a pharmaceutically acceptable salt thereof, wherein A is H.

Metadata:
- Claim Count in Document: 41.0
- Percentile: 95.0
- Lexical Diversity: 1.44444
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15526361', '14275879', '15685588', '15157624', '15526360']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8244425348140288
- 35 USC 102 Novelty (BERT): 0.5498589709615791
- Combined Prediction Score: 0.7969841784287839
- Mean Citation Score: 392.438648
- Max Citation Score: 410.2486
- Similarity Product: 349.97425397069463

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test